Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the efficacy and safety of first-line icotinib treatment
and first-line chemotherapy followed by maintenance treatment with icotinib.